Starlight Therapeutics, a wholly-owned subsidiary of Lantern Pharmaceuticals (NASDAQ: LTRN), formed to develop transformative ...

Boston Scientific Corporation will participate in the 2024 UBS Global Healthcare Conference on Tuesday, November 12, 2024.

Torrent Investments, a promoter entity of Torrent Pharmaceuticals, has offloaded a total of 99.44 lakh shares or 2.94 per ...

Orsini has been chosen by Cycle Pharmaceuticals to distribute SAJAZIRtm (icatibant) Injection, a subcutaneous treatment for acute attacks of hereditary angioedema (HAE) in adults 18 years of age and ...

Third quarter 2024 total revenue grew 42% versus prior year to $139 million, including Crysvita® revenue of $98 million and Dojolvi® revenue of ...

November 04, 2024 I Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients ...

The ROS-1 NSCLC current market is mainly dominated by tyrosine kinase inhibitors such as XALKORI at present and is ...

STAT Plus: Medicare Advantage insurers ramped up use of technology to deny claims, Senate investigation shows ...

Canara Robeco Conservative Hybrid Fund (IDCW-M) 5.52 20,100 0.57 Canara Robeco Conservative Hybrid Fund-Dir (G) 5.52 20,100 0.57 Canara Robeco Conservative Hybrid ...

Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 81,108.95 Crore) operating in Pharmaceuticals sector. Aurobindo Pharma Ltd. key Products/Revenue ...